Identification of an emphysema-associated genetic variant near TGFB2 with regulatory effects in lung fibroblasts

  1. Margaret M Parker
  2. Yuan Hao
  3. Feng Guo
  4. Betty Pham
  5. Robert Chase
  6. John Platig
  7. Michael H Cho
  8. Craig P Hersh
  9. Victor J Thannickal
  10. James Crapo
  11. George Washko
  12. Scott H Randell
  13. Edwin K Silverman
  14. Raúl San José Estépar
  15. Xiaobo Zhou  Is a corresponding author
  16. Peter J Castaldi  Is a corresponding author
  1. Brigham and Women's Hospital, United States
  2. University of Alabama at Birmingham, United States
  3. National Jewish Health, United States
  4. University of North Carolina at Chapel Hill, United States

Abstract

Murine studies have linked TGF-b signaling to emphysema, and human genome-wide association studies (GWAS) studies of lung function and COPD have identified associated regions near genes in the TGF-b superfamily. However, the functional regulatory mechanisms at these loci have not been identified. We performed the largest GWAS of emphysema patterns to date, identifying ten GWAS loci including an association peak spanning a 200kb region downstream from TGFB2. Integrative analysis of publicly available eQTL, DNaseI, and chromatin conformation data identified a putative functional variant, rs1690789, that may regulate TGFB2 expression in human fibroblasts. Using chromatin conformation capture, we confirmed that the region containing rs1690789 contacts the TGFB2 promoter in fibroblasts, and CRISPR/Cas-9 targeted deletion of a ~100bp region containing rs1690789 resulted in decreased TGFB2 expression in primary human lung fibroblasts. These data provide novel mechanistic evidence linking genetic variation affecting the TGF-b pathway to emphysema in humans.

Data availability

COPDGene genetic data and RNA-seq data have been deposited in dbGaP under accession code phs000765.v3.p2. To access these data users may apply for access to the dbGaP data repository (https://www.ncbi.nlm.nih.gov/books/NBK482114/).

The following data sets were generated
The following previously published data sets were used

Article and author information

Author details

  1. Margaret M Parker

    Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, United States
    Competing interests
    No competing interests declared.
  2. Yuan Hao

    Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, United States
    Competing interests
    No competing interests declared.
  3. Feng Guo

    Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, United States
    Competing interests
    No competing interests declared.
  4. Betty Pham

    Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, United States
    Competing interests
    No competing interests declared.
  5. Robert Chase

    Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, United States
    Competing interests
    No competing interests declared.
  6. John Platig

    Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, United States
    Competing interests
    No competing interests declared.
  7. Michael H Cho

    Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, United States
    Competing interests
    Michael H Cho, reports grants from GSK and personal fees from Genentech.
  8. Craig P Hersh

    Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, United States
    Competing interests
    Craig P Hersh, reports personal fees from Mylan, personal fees from AstraZeneca, Concert Pharmaceuticals, 23andMe, grants from Novartis, and Boehringer-Ingelheim.
  9. Victor J Thannickal

    Department of Medicine, University of Alabama at Birmingham, Birmingham, United States
    Competing interests
    No competing interests declared.
  10. James Crapo

    National Jewish Health, Denver, United States
    Competing interests
    No competing interests declared.
  11. George Washko

    Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Boston, United States
    Competing interests
    George Washko, reports grants and other support from Boehringer Ingelheim, PulmonX, BTG Interventional Medicine, Janssen Pharmaceuticals, and GSK.
  12. Scott H Randell

    Marsico Lung Institute, University of North Carolina at Chapel Hill, Chapel Hill, United States
    Competing interests
    Scott H Randell, reports receiving personal fees from Amgen.
  13. Edwin K Silverman

    Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, United States
    Competing interests
    Edwin K Silverman, received honoraria from Novartis for Continuing Medical Education Seminars and grant and travel support from GlaxoSmithKline.
  14. Raúl San José Estépar

    Applied Chest Imaging Laboratory, Brigham and Women's Hospital, Boston, United States
    Competing interests
    Raúl San José Estépar, reports personal fees from Boehringer Ingelheim, Eolo Medical, and Toshiba.
  15. Xiaobo Zhou

    Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, United States
    For correspondence
    xiaobo.zhou@channing.harvard.edu
    Competing interests
    No competing interests declared.
  16. Peter J Castaldi

    Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, United States
    For correspondence
    peter.castaldi@channing.harvard.edu
    Competing interests
    Peter J Castaldi, has received research support and consulting fees from GSK and Novartis.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-9920-4713

Funding

National Heart, Lung, and Blood Institute (R01 HL124233)

  • Peter J Castaldi

National Heart, Lung, and Blood Institute (R01 HL126596)

  • Peter J Castaldi

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Andrew P Morris, University of Liverpool, United Kingdom

Version history

  1. Received: October 9, 2018
  2. Accepted: July 25, 2019
  3. Accepted Manuscript published: July 25, 2019 (version 1)
  4. Version of Record published: August 14, 2019 (version 2)

Copyright

© 2019, Parker et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,648
    Page views
  • 189
    Downloads
  • 18
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Margaret M Parker
  2. Yuan Hao
  3. Feng Guo
  4. Betty Pham
  5. Robert Chase
  6. John Platig
  7. Michael H Cho
  8. Craig P Hersh
  9. Victor J Thannickal
  10. James Crapo
  11. George Washko
  12. Scott H Randell
  13. Edwin K Silverman
  14. Raúl San José Estépar
  15. Xiaobo Zhou
  16. Peter J Castaldi
(2019)
Identification of an emphysema-associated genetic variant near TGFB2 with regulatory effects in lung fibroblasts
eLife 8:e42720.
https://doi.org/10.7554/eLife.42720

Share this article

https://doi.org/10.7554/eLife.42720

Further reading

    1. Genetics and Genomics
    Songyuan Wu, Xiaoling Tong ... Fangyin Dai
    Research Article

    The color pattern of insects is one of the most diverse adaptive evolutionary phenotypes. However, the molecular regulation of this color pattern is not fully understood. In this study, we found that the transcription factor Bm-mamo is responsible for black dilute (bd) allele mutations in the silkworm. Bm-mamo belongs to the BTB zinc finger family and is orthologous to mamo in Drosophila melanogaster. This gene has a conserved function in gamete production in Drosophila and silkworms and has evolved a pleiotropic function in the regulation of color patterns in caterpillars. Using RNAi and clustered regularly interspaced short palindromic repeats (CRISPR) technology, we showed that Bm-mamo is a repressor of dark melanin patterns in the larval epidermis. Using in vitro binding assays and gene expression profiling in wild-type and mutant larvae, we also showed that Bm-mamo likely regulates the expression of related pigment synthesis and cuticular protein genes in a coordinated manner to mediate its role in color pattern formation. This mechanism is consistent with the dual role of this transcription factor in regulating both the structure and shape of the cuticle and the pigments that are embedded within it. This study provides new insight into the regulation of color patterns as well as into the construction of more complex epidermal features in some insects.

    1. Chromosomes and Gene Expression
    2. Genetics and Genomics
    Maria L Adelus, Jiacheng Ding ... Casey E Romanoski
    Research Article

    Heterogeneity in endothelial cell (EC) sub-phenotypes is becoming increasingly appreciated in atherosclerosis progression. Still, studies quantifying EC heterogeneity across whole transcriptomes and epigenomes in both in vitro and in vivo models are lacking. Multiomic profiling concurrently measuring transcriptomes and accessible chromatin in the same single cells was performed on six distinct primary cultures of human aortic ECs (HAECs) exposed to activating environments characteristic of the atherosclerotic microenvironment in vitro. Meta-analysis of single-cell transcriptomes across 17 human ex vivo arterial specimens was performed and two computational approaches quantitatively evaluated the similarity in molecular profiles between heterogeneous in vitro and ex vivo cell profiles. HAEC cultures were reproducibly populated by four major clusters with distinct pathway enrichment profiles and modest heterogeneous responses: EC1-angiogenic, EC2-proliferative, EC3-activated/mesenchymal-like, and EC4-mesenchymal. Quantitative comparisons between in vitro and ex vivo transcriptomes confirmed EC1 and EC2 as most canonically EC-like, and EC4 as most mesenchymal with minimal effects elicited by siERG and IL1B. Lastly, accessible chromatin regions unique to EC2 and EC4 were most enriched for coronary artery disease (CAD)-associated single-nucleotide polymorphisms from Genome Wide Association Studies (GWAS), suggesting that these cell phenotypes harbor CAD-modulating mechanisms. Primary EC cultures contain markedly heterogeneous cell subtypes defined by their molecular profiles. Surprisingly, the perturbations used here only modestly shifted cells between subpopulations, suggesting relatively stable molecular phenotypes in culture. Identifying consistently heterogeneous EC subpopulations between in vitro and ex vivo models should pave the way for improving in vitro systems while enabling the mechanisms governing heterogeneous cell state decisions.